Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.
Press releases published on April 17, 2025
Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients
GlobeNewswire
·
April 17, 2025
Ramat Gan, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …
Precision Neuroscience Receives FDA Clearance for High-Resolution Cortical Electrode Array
GlobeNewswire
·
April 17, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for …
Better Choice Company Reinstates Stock Repurchase Program and Increases Authorization to $6.5 Million
GlobeNewswire
·
April 17, 2025
TAMPA, Fla., April 17, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that its Board of Directors has reinstated its stock repurchase program …
Salt Trick For Men: A Revolutionary Leap in Men’s Vitality with "Nitric Boost"
GlobeNewswire
·
April 17, 2025
The 15-second wellness technique from Salt Trick for Men Nitric Boost provides males a revolutionary method to improve their vitality and energy levels and circulation without exercise or diet requirements. NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- The …
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
GlobeNewswire
·
April 17, 2025
Sol-Gel to receive $16 million during 2025 Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trial SGT-610 Phase III clinical trial top-line results are expected in …
Best Probiotics for Women Over 50 - Most Effective Probiotic Supplements for Menopause and Older Females 2025 - YourBiology
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- As a health and wellness professional I get asked all the time what are the best ways to support female health especially for women over 50. At this stage of life gut balance becomes even more important …
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
GlobeNewswire
·
April 17, 2025
WEXFORD, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- COEPTIS, Inc. (Nasdaq: COEP) ("the Company" or "COEPTIS"), a pioneering technology firm at the forefront of innovative biotechnology solutions, is excited to announce the establishment of a new co-working …
Cardarine GW501516 SARMs: Cardarine Before & After Results, Benefits, Side Effects & Dosage – Buy Legal CrazyBulk Supplement
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- As we step into 2025, it is dire to stay informed of synchrony insights regarding bodybuilding supplements, peculiarly SARMs and their rightful as well as substitutes. >> Shop Cardarine on the Official …
Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X
GlobeNewswire
·
April 17, 2025
First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications Enhanced imaging system features sleek design with smaller footprint; simplified ‘plug and …
Notice of General Meeting
GlobeNewswire
·
April 17, 2025
April 17, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …
Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails
GlobeNewswire
·
April 17, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Beverages, the U.S. beverage division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) announces the introduction of Cruisies, a new line of refreshing, ready-to-drink cocktails designed to enhance …
Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 17, 2025
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today announced …
Autism Acceptance Month Shines at Jay Nolan's Vibrant 'Picnic in the Park' Celebration
EIN Presswire
·
April 17, 2025
Families with children with disabilities enjoyed a day of fun, community, and support thanks to local sponsors and Jay Nolan Community Services LOS ANGELES, CA, UNITED STATES, April 16, 2025 /EINPresswire.com/ -- On Sunday, April 13, 2025, Jay Nolan …
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
GlobeNewswire
·
April 17, 2025
Regulatory milestone enables commercial expansion into high-need international market 10-minute test detects early signs of kidney damage using a simple urine sample Addresses global public health burden of Chronic Kidney Disease (CKD), with high relevance …
Clean Remedies Lowers Tincture Prices to Make Wellness More Accessible
EIN Presswire
·
April 17, 2025
Clean Remedies, a wellness company known for its THC and CBD-infused products, has announced a recent price reduction across its line of oils and tinctures. AVON, OH, UNITED STATES, April 16, 2025 /EINPresswire.com/ -- Clean Remedies, a wellness …
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025
GlobeNewswire
·
April 17, 2025
WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Calcivis appoints Greg Sheehan as CEO
GlobeNewswire
·
April 17, 2025
EDINBURGH, United Kingdom, April 17, 2025 (GLOBE NEWSWIRE) -- Edinburgh-based dental imaging technology pioneer, Calcivis, has appointed US dental industry veteran Greg Sheehan as its new Chief Executive Officer. With 28 years’ experience in leading dental …
Hashimoto’s Disease and Other Thyroid Disorders: Treatment Program at Patients Medical
EIN Presswire
·
April 17, 2025
Hashimoto’s Disease: Comprehensive new program combines advanced thyroid testing, holistic care, and personalized hormone therapy for long-term results. NEW YORK, NY, UNITED STATES, April 16, 2025 /EINPresswire.com/ -- Patients Medical Unveils Advanced …
Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 17, 2025
PITTSBURGH, April 17, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its first quarter 2025 financial results on Tuesday, May 6, 2025, prior to …
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
GlobeNewswire
·
April 17, 2025
WellStar Health System to Highlight New BVA-Driven Strategy That Significantly Reduces Kidney Injury Following LVAD Implantation Oak Ridge, TN, April 17, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume …